does glp-1 cross the blood brain barrier Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Brain–Adipocyte Axis | Drugs Repurposing glucagon-like peptide-1 receptor agonists

The choice of formulation depends on the specific medication, the indication (diabetes or weight management), patient preference, and clinical suitability

I have a concern around this shortage being only temporarily resolved, and there being sort of a yo-yo effect of the shortage coming and going over the next year

For some patients, yes

While prescriptions for weight loss medication cannot be guaranteed for every patient, if you are 18 years of age or older and meet specific criteria such as weight and certain associated health conditions, your healthcare provider may consider you eligible for a prescription

Slowing titration or pausing dose increases for a few weeks can restore balance